SCHEMBL7991341

SCHEMBL7991341

O=C1c2cccc(O)c2C(=O)N1CCCO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ HTT P42858 3/20 0.51
▸ PABPC1 P11940 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ RGS12 O14924 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ HEXA P06865 3/20 0.49
▸ HEXB P07686 3/20 0.49
▸ TSHR P16473 2/20 0.48
▸ ANPEP P15144 2/20 0.47
▸ DPP4 P27487 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10909813 0.90 HEXA (0.60) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL14560522 0.86 ANPEP (0.52) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL4959465 0.84 ANPEP (0.51) ALDH1A1KMT2AKDM4EMEN1PABPC1
SCHEMBL14560523 0.83 CDC25A (0.51) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL10699832 0.83 KMT2A (0.65) ALDH1A1KMT2AKDM4EMEN1LMNA
SCHEMBL31540930 0.82 ANPEP (0.55) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL526807 0.81 KDM4E (0.68) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL29459619 0.81 KDM4E (0.68) ALDH1A1KMT2AKDM4EMEN1HTT
SCHEMBL3790518 0.79 KMT2A (0.52) ALDH1A1KMT2AKDM4EMEN1SMN1; SMN2
SCHEMBL10912457 0.79 RAB9A (0.43) ALDH1A1KMT2AMEN1PABPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6121433-A FOR DIAGNOSTIC, RESEARCH AND THERAPEUTIC USE; MIMIC OR MODULATE PROTEINS, ENZYMES, NUCLEIC ACIDS AND LIPIDS ISIS PHARMACEUTICALS, INC. (US) 2000-09-19 — — US disclosed
EP-0746326-A4 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS INC (US) 2000-06-14 — — EP disclosed
EP-0746326-A1 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS, INC. (US) 1996-12-11 — — EP disclosed
WO-1995018623-A1 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS, INC. (US) 1995-07-13 — — WO disclosed
EP-0171977-A1 Phthalimide derivatives, compositions containing them and a process for preparing them SANKYO COMPANY LIMITED (JP) 1986-02-19 — — EP disclosed
Send feedback